Full-Time

Research Associate

Confirmed live in the last 24 hours

BigHat Biosciences

BigHat Biosciences

51-200 employees

Develops AI-driven antibody therapeutics

Data & Analytics
AI & Machine Learning

Junior, Mid

San Mateo, CA, USA

Requirements
  • Bachelor’s or Master’s degree with 1-2 years of relevant industry experience
  • Hands-on experience with protein therapeutics and modern Developability assessment methods such as accelerated stability/forced degradation, polyreactivity, self-reactivity, HIC, SEC, thermostability, and CE-SDS
  • Experience with ELISA and MSD for running high-throughput multiplexed immunoassays
  • Strong record-keeping and organizational skills
  • Possess a can-do mindset for tackling the challenges associated with working in a dynamic fast-paced environment
Responsibilities
  • Performing standard Developability assessments according to established SOPs for assessing antibody purity, stability, tolerability and biophysical properties
  • Routinely performing diverse Developability workflows across all therapeutic programs with efficient time management and organization
  • Carrying out R&D experiments towards new assay development or methods optimization under the guidance of senior Lab personnel
  • Working closely with other Lab teams to coordinate sample preparation and hand-offs
  • Regularly documenting experimental methods and findings according to company policies to help author and review relevant SOPs
  • Contributing to internal software tools to automate the capture and analysis of instrument-outputted data files
  • Collaborating with the Automation team for the high-throughput scaling of established assays
  • Contributing to and/or presenting data at team meetings throughout the organization

BigHat Biosciences utilizes machine learning and synthetic biology to develop advanced antibody therapeutics, integrating a high-speed wet lab with AI technologies to accelerate the antibody engineering process, potentially driving the development of safer and more effective treatments for challenging diseases.

Company Stage

Series B

Total Funding

$99.4M

Headquarters

San Mateo, California

Founded

2019

Growth & Insights
Headcount

6 month growth

8%

1 year growth

53%

2 year growth

168%